qRT-PCR and IHC analysis of ATXN2 both revealed that the levels were significantly higher in tumors than in adjacent normal tissue (Figures S3B−S3D), suggesting that ATXN2 may play a role in ESCC development. The gene discussed is ATXN2; the disease is esophageal squamous cell carcinoma.